Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. - Wikidata - awgldk - TriplyDB

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

http://www.wikidata.org/entity/Q34078370

about

CXCR4 in breast cancer: oncogenic role and therapeutic targeting Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges Metastatic mechanisms in follicular cell-derived thyroid cancer AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines Coordinated regulation of myeloid cells by tumours Inflammation and skeletal metastasis Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas STAT3 negatively regulates thyroid tumorigenesis The RET/PTC3 oncogene activates classical NF-κB by stabilizing NIK Tumors as organs: complex tissues that interface with the entire organism Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma.Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients.Urinary neopterin levels in patients with thyroid cancer Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.Hashimoto's thyroiditis pathology and risk for thyroid cancer.Tumor associated macrophages and neutrophils in tumor progression.Immune response in thyroid cancer: widening the boundaries.Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state.Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients.Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer.Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.Cancer Immunity: Lessons From Infectious Diseases Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase/mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (PI3K/MEK) transforming activities emanating from RET/PTC fusion oncoprotein Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study Protumoral TSP50 Regulates Macrophage Activities and Polarization via Production of TNF-α and IL-1β, and Activation of the NF-κB Signaling Pathway.Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma.Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release Interspecies differences in membrane-associated protease activities of thyrocytes and their relevance for thyroid cancer studies.NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas.Monocytes promote liver carcinogenesis in an oncogene-specific manner.Robust Early Inflammation of the Peripancreatic Visceral Adipose Tissue During Diet-Induced Obesity in the KrasG12D Model of Pancreatic Cancer Noncanonical roles of the immune system in eliciting oncogene addiction Targeting tumour-associated macrophages.The immune network in thyroid cancer Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.Aging and inflammation: etiological culprits of cancer The diverse roles of the TNF axis in cancer progression and metastasis.RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma.

P2860

Q26781915-5A623AC6-038B-4FE2-9F66-964E54D77F8C Q26866236-78451875-F77D-4884-A0A6-8686679B80D6 Q27005646-9FADE225-21A6-4C40-84C7-0D75A2CC186E Q27851932-324541F8-FF0E-4212-9F28-F068265CFC49 Q28395157-AB6B5006-6CA9-44F9-8E37-EB11E5DD2A76 Q28396089-A79667B8-116B-4EFE-9B29-CF635B8AACB7 Q28475549-0445E545-1F4A-4865-B68E-3FF2E3D0DB5D Q28505424-F443A457-1AC3-444D-A876-6C1C9C271B0A Q28511823-BC412F26-BB9A-4416-AB76-796698F06938 Q30495528-F97A02B2-1F45-4103-A166-33814727B100 Q33717537-DFBA2809-F6F9-405B-A7D5-1FBDC2048723 Q33773692-668A8795-66E6-4D17-8F51-0B21A40424E0 Q33808410-1B63A51D-0F6E-4356-92EE-578639AE40F6 Q33833972-4750109B-1298-42CB-A77C-3BB2E412579A Q33842294-2D4C290A-74FB-4A48-98AB-990472F9714C Q34306107-EE53FD51-6AA9-446C-8CE0-49FDEA7EF9EA Q34310495-403508F6-61CF-4DD1-8FA4-E368641DF42A Q34467844-80C067C0-D11C-439F-8FFF-AC696A0A4E5F Q34634596-DD05D444-730F-43B5-B1BF-4839356128E5 Q34718996-25606EFC-B343-4C09-8B15-8FBF92A92D37 Q35141951-1E95B8A8-2F31-45BF-9985-C87B4FC0B901 Q35597978-6A42AEEB-9296-4BE5-95A1-57782FE4F613 Q35676186-B67D1E4E-0558-4C4B-BD0E-1DDF65652757 Q35763320-A55C79A6-37C0-40AB-9FC6-69B3E91973EC Q35794786-1C120BDF-3117-464F-9913-5B83525D3798 Q35873426-9864A996-4DBA-442F-A91F-E0B51456BAB2 Q35977327-B3098D4E-254D-4FAA-8300-99D5F2014A1E Q35981563-DCDCAF9A-3A41-4E04-9C66-16AA97C8BCFD Q36175768-29128D41-FE21-43DF-82FF-5A201F4081B8 Q36611016-08602269-53CA-40CF-8E02-0B7414D61197 Q36706259-F084067B-2FED-497E-99A5-261C210BF6C1 Q36862870-896CB883-21F7-4A58-B89F-6F96A8E9302D Q36931816-07D13775-C3A5-4214-8375-11B953A3F1D0 Q36936355-172AED84-6A5E-4872-92F4-43EC6667914A Q37079138-1AC60981-B6E6-48FD-9C1E-5E5FBA698A6D Q37104339-AA2DCECF-CF3D-4387-9F13-9D1D618E5427 Q37295706-A880B62F-D3E0-466F-A232-42FAA2F0FD5D Q37462069-CB7768FD-0410-49A8-8029-EE4F3D7DB5E2 Q37474735-5FB47A94-E1BD-490F-A397-EEE14C567BCF Q37554783-B07F608C-BA46-404B-9912-EF2DAFC1A58F

P2860

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

http://www.wikidata.org/entity/Q34078370

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@ast

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@en

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@nl

type

label

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@ast

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@en

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@nl

prefLabel

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@ast

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@en

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@nl

P1433

Q34078370-93D3931D-4D5B-42B1-B1C3-8ECF995182AF

P1476

Q34078370-594547A8-15B8-46C0-ACAD-9DD9CD3F7340

P2093

Q34078370-0FA06A03-94D3-4AC8-8F70-56F55AF88A48

Q34078370-2FAF8351-FF43-4C3D-BFA8-06175FC1A22B

Q34078370-4C277AE4-B775-42B0-8D1F-E249831F5FE9

Q34078370-5882945A-AC64-4CCA-90F5-712915C2CD51

Q34078370-95A1CF95-81B0-4454-BD65-51CDC71782C3

Q34078370-D1F6DFB6-6D2F-469A-B6F0-D01BAD8C1F6B

Q34078370-DD208F75-0208-4A02-9042-B1C6BE408482

Q34078370-EB58F805-0B1F-4031-B455-A0E16C0E7179

P2860

Q34078370-07FA27E7-DBB1-4AB5-9F0A-CCBC9ACA90DB

Q34078370-083226DE-70C0-41D1-9FDD-E18D36CB6DE1

Q34078370-130488EB-86CD-4E0C-9C83-93289F2EC7E4

Q34078370-169C30A6-DF03-4098-9BD6-CE9020DD5337

Q34078370-1F2EAF70-84ED-4423-B78C-4688F3EA84B1

Q34078370-1F34BDDA-10EF-45C7-B948-C8DA59BE9F7A

Q34078370-22DD5C96-213A-490C-A48F-857D12D620CD

Q34078370-23206D35-A6B9-4900-B185-CEF50A8772CE

Q34078370-25423141-1444-44B0-8468-441C48189F00

Q34078370-38E68C21-1C3C-4BD4-9733-891703572496

P304

Q34078370-8BECD3CA-5A25-4456-A7B2-DE2E0F88ECCD

P31

Q34078370-22106BD6-3ED4-47D9-B4DA-B16F4501B9F3

P356

Q34078370-A4B718C7-99D4-406F-B046-E77D399863A8

P407

Q34078370-BECDF4D0-BA9B-45F5-A462-C510A8A708CF

P433

Q34078370-AD80A4EC-6849-404F-9810-B4E52E3D396C

P478

Q34078370-F3817CA8-3542-4A0F-8733-E99A0B466619

P50

Q34078370-2DDFBE92-BF5F-4C4D-ACDD-057A92E12229

Q34078370-4845F92B-7E4C-4FFA-B5DC-460A903C8810

Q34078370-4FB4CE49-B179-4CC7-8BCC-D48407EF94AF

Q34078370-80565B3C-4219-4E24-8B2A-EB6BDCFBC05B

Q34078370-B24A2DAE-DFF6-43CB-BD8A-5CF065FDC18D

Q34078370-C0C9CA8C-53DB-489E-9165-8B463AC0BEE7

Q34078370-C6316B9D-C7A6-49F6-8C35-C700A80B5C8D

Q34078370-FA82BF33-6F67-4915-9B37-A4FAE9D73DC2

P577

Q34078370-243CF761-345E-44C8-9944-8440E17A5A56

P5875

Q34078370-FC70C937-9A31-4AA1-B7C7-148FD7ADCF0B

P698

Q34078370-249550CC-D483-470C-AD1C-4B0551FB0D74

P932

Q34078370-ED610F6A-AA41-45E7-8955-5E5EF4289BE5

P356

PNAS.0503039102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Induction of a proinflammatory ...... ytes by the RET/PTC1 oncogene.

@en

P2093

Cristina Ferrario

http://www.w3.org/2001/XMLSchema#string

Debora Degl'innocenti

http://www.w3.org/2001/XMLSchema#string

Laura Fugazzola

http://www.w3.org/2001/XMLSchema#string

Luisella Alberti

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Borrello

http://www.w3.org/2001/XMLSchema#string

Paola Allavena

http://www.w3.org/2001/XMLSchema#string

Paola Bressan

http://www.w3.org/2001/XMLSchema#string

Silvana Pilotti

http://www.w3.org/2001/XMLSchema#string

P2860

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

Inflammation and cancer

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.

Inflammation and cancer: back to Virchow?

RET tyrosine kinase signaling in development and cancer

Cancer and the chemokine network

IL-1 is required for tumor invasiveness and angiogenesis

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Tumour-educated macrophages promote tumour progression and metastasis

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

P304

14825-14830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0503039102

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Mantovani

Marco A. Pierotti

Federica Marchesi

Manuela Gariboldi

Giuliana Cassinelli

P577

2005-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7561236

http://www.w3.org/2001/XMLSchema#string

P698

16203990

http://www.w3.org/2001/XMLSchema#string

P932

1253545

http://www.w3.org/2001/XMLSchema#string